Cargando…

Pembrolizumab for cutaneous squamous cell carcinoma: Report of a case of inoperable squamous cell carcinoma with complete response to pembrolizumab complicated by granulomatous inflammation

Detalles Bibliográficos
Autores principales: van Baar, Mireille L.M., Guminski, Alex D., Ferguson, Peter M., Martin, Linda K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536769/
https://www.ncbi.nlm.nih.gov/pubmed/31193588
http://dx.doi.org/10.1016/j.jdcr.2019.04.006
_version_ 1783421841079009280
author van Baar, Mireille L.M.
Guminski, Alex D.
Ferguson, Peter M.
Martin, Linda K.
author_facet van Baar, Mireille L.M.
Guminski, Alex D.
Ferguson, Peter M.
Martin, Linda K.
author_sort van Baar, Mireille L.M.
collection PubMed
description
format Online
Article
Text
id pubmed-6536769
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-65367692019-06-03 Pembrolizumab for cutaneous squamous cell carcinoma: Report of a case of inoperable squamous cell carcinoma with complete response to pembrolizumab complicated by granulomatous inflammation van Baar, Mireille L.M. Guminski, Alex D. Ferguson, Peter M. Martin, Linda K. JAAD Case Rep Case Report Elsevier 2019-05-25 /pmc/articles/PMC6536769/ /pubmed/31193588 http://dx.doi.org/10.1016/j.jdcr.2019.04.006 Text en © 2019 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
van Baar, Mireille L.M.
Guminski, Alex D.
Ferguson, Peter M.
Martin, Linda K.
Pembrolizumab for cutaneous squamous cell carcinoma: Report of a case of inoperable squamous cell carcinoma with complete response to pembrolizumab complicated by granulomatous inflammation
title Pembrolizumab for cutaneous squamous cell carcinoma: Report of a case of inoperable squamous cell carcinoma with complete response to pembrolizumab complicated by granulomatous inflammation
title_full Pembrolizumab for cutaneous squamous cell carcinoma: Report of a case of inoperable squamous cell carcinoma with complete response to pembrolizumab complicated by granulomatous inflammation
title_fullStr Pembrolizumab for cutaneous squamous cell carcinoma: Report of a case of inoperable squamous cell carcinoma with complete response to pembrolizumab complicated by granulomatous inflammation
title_full_unstemmed Pembrolizumab for cutaneous squamous cell carcinoma: Report of a case of inoperable squamous cell carcinoma with complete response to pembrolizumab complicated by granulomatous inflammation
title_short Pembrolizumab for cutaneous squamous cell carcinoma: Report of a case of inoperable squamous cell carcinoma with complete response to pembrolizumab complicated by granulomatous inflammation
title_sort pembrolizumab for cutaneous squamous cell carcinoma: report of a case of inoperable squamous cell carcinoma with complete response to pembrolizumab complicated by granulomatous inflammation
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536769/
https://www.ncbi.nlm.nih.gov/pubmed/31193588
http://dx.doi.org/10.1016/j.jdcr.2019.04.006
work_keys_str_mv AT vanbaarmireillelm pembrolizumabforcutaneoussquamouscellcarcinomareportofacaseofinoperablesquamouscellcarcinomawithcompleteresponsetopembrolizumabcomplicatedbygranulomatousinflammation
AT guminskialexd pembrolizumabforcutaneoussquamouscellcarcinomareportofacaseofinoperablesquamouscellcarcinomawithcompleteresponsetopembrolizumabcomplicatedbygranulomatousinflammation
AT fergusonpeterm pembrolizumabforcutaneoussquamouscellcarcinomareportofacaseofinoperablesquamouscellcarcinomawithcompleteresponsetopembrolizumabcomplicatedbygranulomatousinflammation
AT martinlindak pembrolizumabforcutaneoussquamouscellcarcinomareportofacaseofinoperablesquamouscellcarcinomawithcompleteresponsetopembrolizumabcomplicatedbygranulomatousinflammation